REGN-COV2 antibody cocktail in patients with SARS-CoV-2: Observational study from a single institution in Japan

INTRODUCTION: A new treatment for coronavirus disease (COVID-19), REGN-COV2, a cocktail consisting of two neutralizing antibodies against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), has been approved for patients at a risk of developing more severe disease. METHODS: We retrospectiv...

Descripción completa

Detalles Bibliográficos
Autores principales: Sakurai, Ayana, Marshall, Shoko, Ogasawara, Tomoko, Ogasawara, Toshie, Aoka, Yoshikazu, Sakura, Hiroshi, Uchigata, Yasuko, Ogawa, Tetsuya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986486/
https://www.ncbi.nlm.nih.gov/pubmed/35414436
http://dx.doi.org/10.1016/j.jiac.2022.03.029

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8986486/
https://www.ncbi.nlm.nih.gov/pubmed/35414436
http://dx.doi.org/10.1016/j.jiac.2022.03.029

Ejemplares similares